No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.
<h4>Background</h4>Narcolepsy cataplexy syndrome, characterised by excessive daytime sleepiness and cataplexy, is strongly associated with a genetic marker, human leukocyte antigen (HLA) DQB1*06:02. A sudden increase in the incidence of childhood narcolepsy was observed after vaccination...
Guardado en:
Autores principales: | Krister Melén, Markku Partinen, Janne Tynell, Maarit Sillanpää, Sari-Leena Himanen, Outi Saarenpää-Heikkilä, Christer Hublin, Päivi Olsen, Jorma Ilonen, Hanna Nohynek, Ritva Syrjänen, Terhi Kilpi, Arja Vuorela, Turkka Kirjavainen, Outi Vaarala, Ilkka Julkunen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc57afbba58049b8bf802992379f10b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.
por: Hanna Nohynek, et al.
Publicado: (2012) -
Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1
por: A. Vuorela, et al.
Publicado: (2021) -
Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.
por: Markku Partinen, et al.
Publicado: (2012) -
No evidence for activation of TH1 or TH17 pathways in unstimulated peripheral blood mononuclear cells from children with &beta;-cell autoimmunity or T1D
por: Jenny Walld&eacute;n, et al.
Publicado: (2008) -
Metsänhoitoyhdistykset METSO-ohjelman toimeenpanossa
por: Riikka Paloniemi, et al.
Publicado: (2015)